Related references
Note: Only part of the references are listed.Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
Alexander D. Le et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Epidemiology Characteristics and Trends of Lung Cancer Incidence in Iran
Zeinab Almasi et al.
Asian Pacific Journal of Cancer Prevention (2016)
Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma
Peng Sun et al.
ONCOTARGETS AND THERAPY (2016)
Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer
Josip Joachim Grah et al.
TUMORI JOURNAL (2014)
Assessment of MAGE-A Expression in Resected Non-Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
Maha Ayyoub et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Pattern of cancer/testis antigen expression in lung cancer patients
Yeong-Dae Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
Lynnette Marcar et al.
CANCER RESEARCH (2010)
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Jennifer M. Doyle et al.
MOLECULAR CELL (2010)
The X chromosome in immune functions: when a chromosome makes the difference
Claude Libert et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy
A Akcakanat et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer
AO Gure et al.
CLINICAL CANCER RESEARCH (2005)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
RA Blaheta et al.
MEDICINAL RESEARCH REVIEWS (2005)
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
DNA methylation and cancer therapy: new developments and expectations
M Esteller
CURRENT OPINION IN ONCOLOGY (2005)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
QY Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tissue microarray evaluation of melanoma antigen E (MAGE) tumor-associated antigen expression - Potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
M Bolli et al.
ANNALS OF SURGERY (2002)
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
M Daskalakis et al.
BLOOD (2002)
Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study
T Kocher et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study
R Kavalar et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
A. A. Jungbluth et al.
BRITISH JOURNAL OF CANCER (2000)
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
JF Costello et al.
NATURE GENETICS (2000)